Overview
Cortisone acetate was first isolate in 1935 and became more widely researched in 1949. Since then, glucocorticoids such as cortisone acetate have been used to treat a number of inflammatory conditions such as endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders. Cortisone acetate was granted FDA approval on 13 June 1950.
Indication
Cortisone acetate is indicated to treat a wide variety of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders.
Associated Conditions
- Acute Gouty Arthritis
- Acute Leukemia
- Adrenocortical Hyperfunction
- Adrenocortical Insufficiency
- Allergic Conjunctivitis (AC)
- Ankylosing Spondylitis (AS)
- Aspiration Pneumonitis
- Asthma
- Atopic Dermatitis
- Berylliosis
- Bullous dermatitis herpetiformis
- Bursitis
- Chorioretinitis
- Choroiditis
- Congenital Adrenal Hyperplasia (CAH)
- Congenital Hypoplastic Anemia
- Contact Dermatitis
- Cushing's Syndrome
- Drug hypersensitivity reaction
- Epicondylitis
- Erythroblastopenia
- Hypercalcemia of Malignancy
- Immune Thrombocytopenia (ITP)
- Inflammation
- Iridocyclitis
- Iritis
- Keratitis
- Loeffler's syndrome
- Lymphoma
- Meningitis caused by Mycobacterium Tuberculosis
- Mycosis Fungoides (MF)
- Ophthalmia, Sympathetic
- Optic Neuritis
- Pemphigus
- Perennial Allergic Rhinitis (PAR)
- Posttraumatic Osteoarthritis
- Psoriatic Arthritis
- Regional Enteritis
- Rheumatoid Arthritis
- Rheumatoid Arthritis, Juvenile
- Rosacea
- Seasonal Allergic Rhinitis
- Secondary thrombocytopenia
- Serum Sickness
- Severe Seborrheic Dermatitis
- Stevens-Johnson Syndrome
- Synovitis
- Systemic Lupus Erythematosus
- Tenosynovitis
- Trichinosis
- Tuberculosis (TB)
- Ulcerative Colitis
- Uveitis
- Acquired immune hemolytic anemia
- Acute rheumatic carditis
- Anterior eye segment inflammation
- Exfoliative erythroderma
- Non-suppurative Thyroiditis
- Severe Psoriasis
- Symptomatic Sarcoidosis
- Varicella-zoster virus acute retinal necrosis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2013/04/30 | Phase 3 | Completed | Technical University of Munich | ||
2013/01/18 | Phase 2 | UNKNOWN | Haukeland University Hospital |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Dr. Donna Restivo DC | 62185-0050 | ORAL | 12 [hp_X] in 1 mL | 5/23/2025 | |
| King Bio Inc. | 57955-2819 | ORAL | 10 [hp_X] in 59 mL | 5/20/2025 | |
| Chartwell RX, LLC | 62135-173 | ORAL | 25 mg in 1 1 | 1/19/2023 | |
| Deseret Biologicals, Inc. | 43742-2246 | ORAL | 13 [hp_X] in 1 mL | 5/27/2025 | |
| King Bio Inc. | 57955-0762 | ORAL | 12 [hp_X] in 59 mL | 5/20/2025 | |
| King Bio Inc. | 57955-4809 | ORAL | 12 [hp_X] in 118 mL | 5/2/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CORTATE cortisone acetate 5mg tablet bottle | 27912 | Medicine | A | 10/21/1991 | |
| CORTATE cortisone acetate 25mg tablet bottle | 27910 | Medicine | A | 10/21/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| CORTONE TAB 5MG | merck frosst canada & cie, merck frosst canada & co. | 00016438 | Tablet - Oral | 5 MG | 12/31/1951 |
| CORTISONE ACETATE | bausch health, canada inc. | 00280437 | Tablet - Oral | 25 MG | 12/31/1973 |
| CORTONE SUS 50MG/ML | merck frosst canada & cie, merck frosst canada & co. | 00016241 | Suspension - Intramuscular | 50 MG / ML | 12/31/1951 |
| CORTONE TAB 25MG | merck frosst canada & cie, merck frosst canada & co. | 00016446 | Tablet - Oral | 25 MG | 12/31/1954 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.